Exact Mass: 327.09046420000004
Exact Mass Matches: 327.09046420000004
Found 326 metabolites which its exact mass value is equals to given mass value 327.09046420000004,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Fluazifop
D010575 - Pesticides > D006540 - Herbicides D016573 - Agrochemicals
Loxapine
Loxapine is only found in individuals that have used or taken this drug. It is an antipsychotic agent used in schizophrenia. [PubChem]Loxapine is a dopamine antagonist, and also a serotonin 5-HT2 blocker. The exact mode of action of Loxapine has not been established, however changes in the level of excitability of subcortical inhibitory areas have been observed in several animal species in association with such manifestations of tranquilization as calming effects and suppression of aggressive behavior. N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AH - Diazepines, oxazepines, thiazepines and oxepines D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Loxapine is an orally active dopamine inhibitor, 5-HT receptor antagonist and also a dibenzoxazepine anti-psychotic agent[1][4].
Etaconazole
3-methylthiopropyl-desulfoglucosinolate
C11H21NO6S2 (327.08102460000003)
Robenacoxib
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic
deoxyviolacein
A member of the class of oxindoles resulting from formal oxidative coupling between the 3-position of 1,3-dihydro-2H-indol-2-one and the 3-position of 1,3-dihydro-2H-pyrrol-2-one, which is substituted at the 5 position by a 1H-indol-3-yl group, where the newly-formed double bond has E configuration.
Acetaminophen glucuronide
Acetaminophen glucuronide is a natural human metabolite of Acetaminophen generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. Acetaminophen glucuronide is found to be associated with beta-thalassemia, which is an inborn error of metabolism. Acetaminophen glucuronide is a natural human metabolite of Acetaminophen generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. [HMDB]
N-(4-Hydroxycinnamoyl)tyrosine
Natural food antioxidant. Isolated from cocoa liquor (Theobroma cacao). N-(4-Hydroxycinnamoyl)tyrosine is found in cocoa and cocoa products and cocoa powder. N-(4-Hydroxycinnamoyl)tyrosine is found in cocoa and cocoa products. Natural food antioxidant. It is isolated from cocoa liquor (Theobroma cacao).
Blepharin
Glycoside from seedlings of rye and sweet corn (Zea mays). Blepharin is found in cereals and cereal products, fats and oils, and corn. Blepharin is found in cereals and cereal products. Blepharin is a glycoside from seedlings of rye and sweet corn (Zea mays
N-(1-Deoxy-1-fructosyl)phenylalanine
C15H21NO7 (327.13179560000003)
Fructose aminoacids are naturally occurring compounds derived from D-fructose and L-aminoacids. They are amadori products resulting from sugar-aminoacid interactions in food products, especially cooked foods [CCD] N-(1-Deoxy-1-fructosyl)phenylalanine is classified as a Natural Food Constituent (code WA) in the DFC.
desethylamodiaquine
desethylamodiaquine is a metabolite of amodiaquine. Amodiaquine (trade names Camoquin, Flavoquine) is a 4-aminoquinoline compound related to chloroquine, used as an antimalarial and anti-inflammatory agent. Amodiaquine has been shown to be more effective than chloroquine in treating CRPF (chloroquine-resistant Plasmodium falciparum) malaria infections and may afford more protection than chloroquine when used as weekly prophylaxis. Amodiaquine, like chloroquine, is generally well tolerated. (Wikipedia)
(2S,3S,4S,5R)-6-(4-Acetamidophenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid
Benzoic acid, 2-[[3-(3,4-dimethoxyphenyl)-1-oxo-2-propenyl]amino]-
Clofibride
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98150 - Fibrate Antilipidemic Agent C - Cardiovascular system > C10 - Lipid modifying agents > C10A - Lipid modifying agents, plain > C10AB - Fibrates
Leteprinim
C15H13N5O4 (327.09674980000005)
(5S)-5-(7-Benzofuranyl)-8-chloro-3-methyl-1,2,4,5-tetrahydro-3-benzazepin-7-ol
Robenacoxib
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic
3-methylthiopropyl-desulfoglucosinolate
C11H21NO6S2 (327.08102460000003)
3-methylthiopropyl-desulfoglucosinolate is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). 3-methylthiopropyl-desulfoglucosinolate can be found in a number of food items such as caraway, lemon thyme, wakame, and papaya, which makes 3-methylthiopropyl-desulfoglucosinolate a potential biomarker for the consumption of these food products.
4-coumaroyl-4'-hydroxyphenyllactate
4-coumaroyl-4-hydroxyphenyllactate is practically insoluble (in water) and a weakly acidic compound (based on its pKa). 4-coumaroyl-4-hydroxyphenyllactate can be found in a number of food items such as sourdock, summer savory, hazelnut, and thistle, which makes 4-coumaroyl-4-hydroxyphenyllactate a potential biomarker for the consumption of these food products.
1,3-Dioxolo(4,5-g)furo(2,3-b)quinoline, 9-methoxy-4-((3-methyl-2-butenyl)oxy)-
3-Methyl-6-oxo-1-phenyl-4-(3-pyridinyl)-6,7-dihydro-1H-pyrazolo[3,4-b]pyridine-5-carbonitrile
3-(5-Isopropyl-3,8-dimethylazulen-1-yl)-2-(methylsulfonyl)acrylonitrile
C19H21NO2S (327.12929260000004)
methyl N-{4-[(alpha-L-rhamnopyranosyl)benzyl]}carbamate
C15H21NO7 (327.13179560000003)
(S,E)-2-(3-(3,4-dihydroxyphenyl)acrylamido)-3-phenylpropanoic acid|2-[3-(3,4-dihydroxy-phenyl)-acryloylamino]-3-phenylpropionic acid|N-trans-caffeoyl-L-phenylalanine
1-(2-hydroxy-4-methoxyphenylamino)-1-deoxy-beta-D-glucopyranoside-1,2-carbamate
8-Hydroxy-5,7-Dimethoxy-4-(4-methoxyphenyl)-2(1H)-quinolinone
proviolacein
A hydroxyindole that is 2H-pyrrol-2-one which is substituted at positions 3 and 5 by 1H-indol-3-yl and 5-hydroxy-1H-indol-3-yl groups, respectively. It is an intermediate in the biosynthesis of the purple chromobacterial pigment violacein from L-tryptophan.
O1-(2-oxo-2,3-dihydro-benzoxazol-6-yl)-beta-D-glucopyranuronic acid|O1-(2-Oxo-2,3-dihydro-benzoxazol-6-yl)-beta-D-glucopyranuronsaeure
(E) methyl 2-[2-oxo-1-(2,3,5-trihydroxyphenyl)-1,2-dihydro-3H-indol-3-ylidene]acetate|costinone A
1-Deoxy-1-L-phenylalanino-D-fructose
C15H21NO7 (327.13179560000003)
(E)-1-(L-cysteinylglycin-S-yl)-N-hydroxy-2-(4-hydroxyphenyl)ethan-1-imine
C13H17N3O5S (327.08888720000004)
Fluazifop
D010575 - Pesticides > D006540 - Herbicides D016573 - Agrochemicals CONFIDENCE standard compound; EAWAG_UCHEM_ID 147 EAWAG_UCHEM_ID 147; CONFIDENCE standard compound
C18H17NO5_L-Tyrosine, N-[(2Z)-3-(4-hydroxyphenyl)-1-oxo-2-propen-1-yl]
C18H17NO5_L-Tyrosine, N-[(2E)-3-(4-hydroxyphenyl)-1-oxo-2-propen-1-yl]
loxapine
N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AH - Diazepines, oxazepines, thiazepines and oxepines D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Loxapine is an orally active dopamine inhibitor, 5-HT receptor antagonist and also a dibenzoxazepine anti-psychotic agent[1][4].
Tranilast
D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002491 - Central Nervous System Agents > D000700 - Analgesics C308 - Immunotherapeutic Agent > C574 - Immunosuppressant D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents D018926 - Anti-Allergic Agents Tranilast (MK-341) acts as an anti-atopic agent. Tranilast suppresses production of prostaglandin D2 (PGD2, IC50= 0.1 mM). Tranilast sodium exhibits anti-inflammatory and immunomodulatory effects[1]. Tranilast sodium antagonizes angiotensin II and inhibits its biological effects in vascular smooth muscle cells[2]. trans-Tranilast (trans-MK-341) is an antiallergic drug, used to treat bronchial asthma, allergic rhinitis and atopic dermatitis. Target: Angiotensin Receptor Tranilast has been approved in Japan and South Korea, since 1982, for the treatment of bronchial asthma, with indications for keloids and hypertrophic scar added in 1993. Tranilast is also used to treat asthma, autoimmune diseases, atopic and fibrotic pathologies, and can also inhibit angiogenesis. The antiproliferative properties of tranilast were found that tranilast elicited an inhibitory effect on fibroblast proliferation in vitro and also suppressed collagen production both in vitro and in vivo . Tranilast also reduced the release of chemical mediators from mast cells and suppressed hypersensitivity reactions. [1] Three-week-old C57Bl/10 and mdx mice received tranilast (~300 mg/kg) in their food for 9 weeks, after which fibrosis was assessed through histological analyses, and functional properties of tibialis anterior muscles were assessed in situ and diaphragm muscle strips in vitro. Tranilast administration did not significantly alter the mass of any muscles in control or mdx mice, but it decreased fibrosis in the severely affected diaphragm muscle by 31\% compared with untreated mdx mice (P< 0.05) [2].
(2S)-3-(4-hydroxyphenyl)-2-[[(Z)-3-(4-hydroxyphenyl)prop-2-enoyl]amino]propanoic acid
N-Fructosyl phenylalanine
C15H21NO7 (327.13179560000003)
Annotation level-3
DICLOBUTRAZOL
PC(2:0/1:0)[U]
C11H22NO8P (327.10829820000004)
Isradipine Metabolite (3,5-Pyridinedicarboxylic acid, 4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-, mo
5-Chloro-2-(3-(hydroxymethyl)-5-methyl-4H-1,2,4-triazol-4-yl)benzophenone
N-trans-P-Coumaroyltyrosine
5,6,7,7a-Tetrahydrothieno[3,2-c]pyridin-2(4H)-one 4-methylbenzenesulfonate
3-[3-(4-methoxyphenoxy)-2-oxopyrrolidin-1-yl]benzoic acid
2-(3,4-DIMETHOXYBENZYL)-3-OXOISOINDOLINE-4-CARBOXYLIC ACID
1-ethyl-1,2-dihydro-6-hydroxy-4-methyl-5-[(2-nitrophenyl)azo]-2-oxonicotinonitrile
C15H13N5O4 (327.09674980000005)
Befunolol hydrochloride
D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists
Benzenesulfonamide,4-methoxy-N-[5-(2-methylpropyl)-1,3,4-thiadiazol-2-yl]-
C13H17N3O3S2 (327.07112920000003)
2-CBZ-6-Hydroxy-1,2,3,4-tetrahydro-isoquinoline-1-carboxylic acid
7-(Dipropylamino)-5,6,7,8-tetrahydro-2-naphthalenol hydrobromide (1:1)
METHYL2-DEOXY-2-[[(PHENYLMETHOXY)CARBONYL]AMINO]-ALPHA-D-GLUCOPYRANOSIDE
C15H21NO7 (327.13179560000003)
8-CHLORO-6-(2-FLUOROPHENYL)-1-METHYL-3A,4-DIHYDRO-3H-BENZO[F]IMIDAZO[1,5-A][1,4]DIAZEPINE
2H-1-Benzopyran-2-one,7-(diethylamino)-3-(2-thienylcarbonyl)-
METHYL 2-FLUORO-3-(PYRROLIDINE-1-CARBONYL)-[1,1-BIPHENYL]-3-CARBOXYLATE
4-(4-bromophenyl)-1,2,36-tetrahydro-1-(phenylmethyl)-pyridine
2-N-BOC-3-(3-CHLORO-PHENYL)-2-METHYLAMINOMETHYL-PROPIONIC ACID
METHYL 2-N-BOC-2-AMINOMETHYL-3-(4-CHLORO-PHENYL)-PROPIONATE
2-methoxy-N-[(1-methylpyrrolidin-2-yl)methyl]-5-sulfamoylbenzamide
ethyl 8-chloro-1-cyclopropyl-6,7-difluoro-4-oxoquinoline-3-carboxylate
9-(3,4-dichlorophenoxy)-3-methyl-3-azaspiro[5.5]undecane
(1R,2S)-1-amino-2-vinylcyclopropanecarboxylic acid ethyl ester tosylate salt
N-[(2R,3S)-2-(2,5-Difluorophenyl)tetrahydro-5-oxo-2H-pyran-3-yl]carbamic acid 1,1-dimethylethyl ester
C16H19F2NO4 (327.12820780000004)
7-(DIPROPYLAMINO)-5,6,7,8-TETRAHYDRONAPHTHALEN-2-OL HYDROBROMIDE
tert-butyl 9-bromo-2,3-dihydrobenzo[f][1,4]oxazepine-4(5H)-carboxylate
Ranimustine
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01A - Alkylating agents > L01AD - Nitrosoureas C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D000970 - Antineoplastic Agents
8-Hydroxy-DPAT hydrobromide
8-OH-DPAT (8-Hydroxy-DPAT) hydrobromide is a potent and selective 5-HT1A agonist with a pIC50 of 8.19. 8-OH-DPAT hydrobromide has selectivity of almost 1000 fold for a subtype of the 5-HT1 binding site[1].
[2-(2-Amino-6-chloro-9H-purin-9-yl)ethyl]propanedioic acid dimethyl ester
BENZYL 4-(((METHYLSULFONYL)OXY)METHYL)PIPERIDINE-1-CARBOXYLATE
METHYL 2-N-BOC-2-AMINOMETHYL-3-(3-CHLORO-PHENYL)-PROPIONATE
2-(1,3-DIOXOISOINDOLIN-2-YL)-1,2,3,4-TETRAHYDROCYCLOPENTA[B]INDOLE-7-CARBONITRILE
(5-BROMO-2-(DIISOPROPYLCARBAMOYL)PHENYL)BORONIC ACID
C13H19BBrNO3 (327.0641274000001)
5-(Chloroacetyl)-8-(phenylmethoxy)-2(1H)-quinolinone
C18H14ClNO3 (327.06621640000003)
Thiamine nitrate
C12H17N5O4S (327.10012020000005)
D018977 - Micronutrients > D014815 - Vitamins Thiamine nitrate is an essential vitamin which can enhance normal neuronal actives.
7-AMINO-4-(PYRIDINE-2-YL-METHYL)-1,4-BENZOXAZIN-3(4H)-ONEDIHYDROCHLORIDE
6-Chloro-4-nitro-1-[[2-(trimethylsilyl)ethoxy]methyl]-1H-pyrrolo[2,3-b]pyridine
2-(5-Chloro-2H-Benzotriazol-2-Yl)-6-(2-Methyl-2-Propanyl)-4-Vinylphenol
Ethyl 2-Nitro-4,5-di(1-pyrazolyl)benzoate
C15H13N5O4 (327.09674980000005)
7-(4-methylsulfanylphenyl)-5-thiophen-2-yl-1,7-dihydrotetrazolo[1,5-a]pyrimidine
Fasudil Hydrochloride
C14H18ClN3O2S (327.08081980000003)
D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators
N-(3-CHLOROPHENYL)-2-(5-(P-TOLYL)-1,2,4-OXADIAZOL-3-YL)ACETAMIDE
4-[2-(DIMETHYLAMINO)ETHYL]PIPERAZINE-1-CARBOXIMIDAMIDE HYDROIODIDE
(3-(2-Nitro-4-(trifluoromethyl)phenoxy)phenyl)boronic acid
C13H9BF3NO5 (327.05258499999997)
7-BENZYL-4-CHLORO-2-(TRIFLUOROMETHYL)-5,6,7,8-TETRAHYDROPYRIDO[3,4-D]PYRIMIDINE
[4-(1,4-dioxa-8-azaspiro[4.5]dec-8-ylsulphonyl)phenyl]boronic acid
C13H18BNO6S (327.0947838000001)
5-(Aminosulfonyl)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-hydroxybenzamide
Phenylthiohydantoin-arginine Hydrochloride
C13H18ClN5OS (327.09205280000003)
1-[2-(Methylsulfonyl)ethyl]-6-oxo-1,6-dihydropyridine-3-boronic Acid Pinacol Ester
C14H22BNO5S (327.13116720000005)
methyl5-cyclopropyl-3-(2-(trifluoromethoxy)phenyl)isoxazole-4-carboxylate
Verosudil
C78283 - Agent Affecting Organs of Special Senses > C29705 - Anti-glaucoma Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor
Methyl 4,6-O-[(S)-(4-nitrophenyl)methylene]-alpha-D-galactopyranoside
N-(2-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanesulfonamide
C14H22BNO5S (327.13116720000005)
1-(5-(TERT-BUTYL)ISOXAZOL-3-YL)-3-(2-(TRIFLUOROMETHYL)PHENYL)UREA
N(ALPHA)-BOC-O-(DIMETHYLPHOSPHO)-L-THREO
C11H22NO8P (327.10829820000004)
7,7-dimethyl-3-[(3-nitrophenyl)methyl]-6,8-dihydrochromene-2,5-dione
Zolamine hydrochloride
C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist
Ethyl 3-hydroxy-3-methyl-1-tosylpyrrolidine-2-carboxylate
(4-(2-NITRO-4-(TRIFLUOROMETHYL)PHENOXY)PHENYL)BORONIC ACID
C13H9BF3NO5 (327.05258499999997)
(4-(N-(Naphthalen-1-yl)sulfamoyl)phenyl)boronic acid
C16H14BNO4S (327.07365540000006)
4,5,6,7-Tetrahydrothieno[3,2-c]pyridin-2(3H)-one 4-methylbenzenesulfonate
(S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one hydrochloride
C14H18ClN3O4 (327.09857780000004)
5-(2-Phenylpyrazolo[1,5-A]pyridin-3-YL)-1H-pyrazolo[3,4-C]pyridazin-3-amine
FR 180204 is an ATP-competitive and selective ERK inhibitor. FR 180204 inhibits ERK1 and ERK2 with IC50s of 0.51 μM (Ki=0.31 μM) and 0.33 μM (Ki=0.14 μM), respectively[1].
6-(2-Fluorobenzyl)-2,4-Dimethyl-4,6-Dihydro-5h-Thieno[2,3:4,5]pyrrolo[2,3-D]pyridazin-5-One
C17H14FN3OS (327.08415660000003)
4-Methyl-N-methyl-N-(2-phenyl-2H-pyrazol-3-YL)benzenesulfonamide
(1r)-2-Phenylacetamido-2-(3-carboxyphenyl)ethyl boronic acid
Leteprinim
C15H13N5O4 (327.09674980000005)
C26170 - Protective Agent > C1509 - Neuroprotective Agent
(+)-5-(7-benzofuranyl)-8-chloro-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-ol
1H-3-Benzazepin-7-ol, 5-(7-benzofuranyl)-8-chloro-2,3,4,5-tetrahydro-3-methyl-, (S)-
Methyl 3-[5-(anilinocarbonyl)-2-furyl]-2-thiophenecarboxylate
C17H13NO4S (327.05652580000003)
5-(2-chlorophenyl)-N-(4-methoxyphenyl)-2-furancarboxamide
C18H14ClNO3 (327.06621640000003)
2-[(4-cyano-1-oxo-5H-pyrido[1,2-a]benzimidazol-3-yl)methylthio]propanoic acid
C16H13N3O3S (327.06775880000004)
6-amino-1-(4-chlorophenyl)-2-oxo-4-(1H-1,2,4-triazol-1-ylmethyl)-1,2-dihydro-5-pyrimidinecarbonitrile
1-(2,3-Dihydro-1,4-benzodioxin-6-yl)-2-([1,2,4]triazolo[4,3-a]pyridin-3-ylthio)ethanone
C16H13N3O3S (327.06775880000004)
2-(2-Hydroxy-biphenyl-3-yl)-1H-indole-5-carboxamidine
4-[3-Methylsulfanylanilino]-6,7-dimethoxyquinazoline
1-(2-Deoxy-5-O-phosphono-beta-D-erythro-pentofuranosyl)-4-methyl-1H-indole
5-(Acetylamino)-3,5-Dideoxy-3-Fluoro-D-Erythro-Alpha-L-Manno-Non-2-Ulopyranosonic Acid
clofibride
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98150 - Fibrate Antilipidemic Agent C - Cardiovascular system > C10 - Lipid modifying agents > C10A - Lipid modifying agents, plain > C10AB - Fibrates
[8-Methoxy-2-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]-piperidin-1-ylmethanone
6-Hydroxymelatoninsulfate
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
pyrano[3,2-a]xanthen-12(1H)-one, 2,3-dihydro-5,9,11-trihydroxy-3,3-dimethyl-
2-[[(2R)-2-amino-3-[(Z)-N-hydroxy-C-[(4-hydroxyphenyl)methyl]carbonimidoyl]sulfanylpropanoyl]amino]acetic acid
C13H17N3O5S (327.08888720000004)
3-(4-hydroxyphenyl)-2-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxypropanoate
[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1E)-N-hydroxy-4-methylsulfanylbutanimidothioate
C11H21NO6S2 (327.08102460000003)
1-[4-Amino-3-[2-(1-pyrrolidinyl)ethylthio]-5-thieno[2,3-c]isothiazolyl]ethanone
3-[(4-methoxybenzylidene)amino]-2,5,6-trimethylthieno[2,3-d]pyrimidin-4(3H)-one
1-Quinolin-8-yl-1,3,4,9-tetrahydropyrido[3,4-b]indole-2-carbaldehyde
N-[2-(2-furanylmethylthio)ethyl]-4-methoxybenzenesulfonamide
4-(3,4-dimethoxyphenyl)-N-(3-methyl-2-pyridinyl)-2-thiazolamine
6-Amino-3-[(2-chlorophenyl)methyl]-2-propyl-4-quinazolinone
4-phenyl-3-[2-(phenylmethylthio)ethyl]-1H-1,2,4-triazole-5-thione
O3-(2-fluorobenzoyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidine-3-carbohydroximamide
1-Hydroxy-3-oxo-6,7-dihydro-3H,5H-pyrido[3,2,1-ij]quinoline-2-carboxylic acid thiazol-2-ylamide
C16H13N3O3S (327.06775880000004)
N-((2,3-Dihydrobenzo[b][1,4]dioxin-2-yl)methyl)-5,6-dimethylthieno[2,3-d]pyrimidin-4-amine
5-(4-methyl-1-naphthalenyl)-N-phenyl-2-furancarboxamide
8-[2-(4-Chloro-3,5-dimethylphenoxy)ethoxy]quinoline
8-[2-(4-Chloro-2,5-dimethylphenoxy)ethoxy]quinoline
3-(2,5-Dimethyl-3-furanyl)-5,6-diphenyl-1,2,4-triazine
4-Hydroxy-2-oxo-1-(prop-2-en-1-yl)-N-(1,3-thiazol-2-yl)-1,2-dihydroquinoline-3-carboxamide
C16H13N3O3S (327.06775880000004)
2-[(3-ethyl-2-quinolinyl)thio]-N-(5-methyl-3-isoxazolyl)acetamide
3-[2-Methoxy-6-(4-methoxyphenyl)-3-pyridinyl]-5-(methoxymethyl)-1,2,4-oxadiazole
5-(2,5-difluorophenyl)-N-(2,6-dimethylphenyl)-2-furancarboxamide
C19H15F2NO2 (327.10707940000003)
3-(4-methoxyphenyl)-3-(1-pyrrolyl)-N-(2-thiazolyl)propanamide
5-tert-butyl-N-[4-(triluoromethyl)phenyl]thiophene-2-carboxamide
C16H16F3NOS (327.09046420000004)
3-(4-oxo-1H-quinazolin-2-yl)propanoic acid (3,5-dimethyl-4-isoxazolyl)methyl ester
N-(3-methoxyphenyl)-N-[6-oxo-4-(trifluoromethyl)-1,6-dihydro-2-pyrimidinyl]guanidine
2-[4-(Cyclohexylsulfamoyl)-2-methylphenoxy]acetic acid
3,5-dimethyl-N-[4-(trifluoromethyl)benzoyl]isoxazole-4-carbohydrazide
C14H12F3N3O3 (327.08307179999997)
4-[4-[(4-Fluorophenyl)methyl]-1-piperidinyl]thieno[2,3-d]pyrimidine
C18H18FN3S (327.12054000000006)
2-[(3S,6aS,8S,10aS)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-thiazolyl)acetamide
2-[(3S,6aS,8R,10aS)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-thiazolyl)acetamide
2-[(3S,6aR,8S,10aR)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(1,3-thiazol-2-yl)acetamide
2-[(3R,6aS,8S,10aS)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-thiazolyl)acetamide
2-[(3S,6aR,8R,10aR)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(1,3-thiazol-2-yl)acetamide
(3Z)-3-[(3-acetyl-4-hydroxy-2-imino-1,3-thiazol-5-yl)methylidene]-7-methylquinolin-2-one
C16H13N3O3S (327.06775880000004)
(1S,2aR,8bR)-N-(4-fluorophenyl)-1-(hydroxymethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinoline-2-carboxamide
2-[(3R,6aR,8S,10aR)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-thiazolyl)acetamide
(1S,2aS,8bS)-N-(4-fluorophenyl)-1-(hydroxymethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinoline-2-carboxamide
(1R,2aR,8bR)-N-(4-fluorophenyl)-1-(hydroxymethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinoline-2-carboxamide
(1R,2aS,8bS)-N-(4-fluorophenyl)-1-(hydroxymethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinoline-2-carboxamide
2-[(3R,6aR,8R,10aR)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-thiazolyl)acetamide
2-[(3R,6aS,8R,10aS)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-thiazolyl)acetamide
N-butyl-N(2)-[(2Z)-2-(2-furyl)-2-(methoxyimino)acetyl]-L-cysteinamide
[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1Z)-N-hydroxy-4-methylsulfanylbutanimidothioate
C11H21NO6S2 (327.08102460000003)
N(2)-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]-N-butyl-L-alaninamide
C13H21N5O3S (327.1365036000001)
(E)-1-(4-fluorophenyl)-N-[5-(4-methoxyphenyl)-4H-1,3,4-thiadiazin-2-yl]methanimine
C17H14FN3OS (327.08415660000003)
7-(diethylamino)-3,4-dioxo-10H-phenoxazine-1-carboxamide
3-methylbut-2-enyl [(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate
(2Z,5E)-5-[(4-hydroxy-3-methoxyphenyl)methylidene]-2-pyridin-2-ylimino-1,3-thiazolidin-4-one
C16H13N3O3S (327.06775880000004)
(5Z)-3-(3,4-dihydroxyphenyl)-5-[(3,4-dihydroxyphenyl)methylidene]-5-oxo-2,5-dihydrofuran-3-olate
[3-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-2-propanoyloxypropyl] propanoate
C11H22NO8P (327.10829820000004)
[1-Acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] butanoate
C11H22NO8P (327.10829820000004)
acetaminophen O-beta-D-glucosiduronic acid
A beta-D-glucosiduronic acid that is the O-glucuronide of paracetamol (acetaminophen).
N-(1-Deoxy-1-fructosyl)phenylalanine
C15H21NO7 (327.13179560000003)
An L-phenylalanine derivative in which one of the amino hydrogens of L-phenylalanine has been replaced by a 1-fructosyl group.
6-amino-1-(4-chlorophenyl)-2-oxo-4-(1,2,4-triazol-1-ylmethyl)-5-pyrimidinecarbonitrile
2-[3-(3,4-dimethoxyphenyl)prop-2-enoylamino]benzoic acid
GLUT1-IN-2
GLUT1-IN-2 (compound 17) is a GLUT1 inhibitor with an IC50 value of 12 μM. GLUT1-IN-2 shows inhibitory effect to Plasmodium falciparum hexose transporter PfHT with an IC50 value of 13 μM. GLUT1-IN-2 can be used for the research of infection[1].
M1001
M1001 is a weak hypoxia-inducible factor-2α (HIF-2α) agonist. M1001 can bind to the HIF-2α PAS-B domain, with a Kd of 667 nM. M1001 can be used in chronic kidney disease research[1].
(1s,2r)-1,6-dihydroxy-2-(2-hydroxypropan-2-yl)-1h,2h,7h-pyrano[3,4-c]carbazol-4-one
n-[(1z,3e)-1,4-bis(3,4-dihydroxyphenyl)-3-methylbuta-1,3-dien-2-yl]carboximidic acid
3,13,23-triazahexacyclo[14.7.0.0²,¹⁰.0⁴,⁹.0¹¹,¹⁵.0¹⁷,²²]tricosa-1(16),2(10),4(9),5,7,11(15),12,17(22),18,20-decaene-6,12-diol
(2r)-3-(3-chloro-4-hydroxyphenyl)-2-{[(2e)-1-hydroxy-4-methoxy-4-oxobut-2-en-1-ylidene]amino}propanoic acid
12-hydroxy-19-methoxy-5,7-dioxa-13-azapentacyclo[11.7.0.0¹,¹⁶.0²,¹⁰.0⁴,⁸]icosa-2,4(8),9,15,17-pentaen-11-one
3,8-dihydroxy-1,10-dimethyl-7h-5-oxa-12-thia-7-azatetraphen-6-one
C17H13NO4S (327.05652580000003)
(e,2e)-3-(1h-indol-3-yl)-n-[(1e)-2-(1h-indol-3-yl)ethenyl]prop-2-enimidic acid
n-[(4-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}phenyl)methyl]methoxycarboximidic acid
C15H21NO7 (327.13179560000003)